Insider · CIK 0002075401

Sandler Laura Lee

Reports to the SEC for 1 company · MENLO PARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0002075401

Forms 4 and 5

Insider transactions

32 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−906 sh	$95.71	−$86.7K	235,478
2026-09-01	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$7.80	+$39K	241,384
2026-09-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,000 sh	$91.05	−$91K	240,384
2026-09-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−4,000 sh	$92.01	−$368K	236,384
2026-09-01	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	74,996
2026-07-01	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$7.80	+$39K	241,384
2026-07-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,237 sh	$93.85	−$210K	239,147
2026-07-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,263 sh	$94.75	−$214K	236,884
2026-07-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−500 sh	$95.47	−$47.7K	236,384
2026-07-01	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	79,996
2026-06-15	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−600 sh	$69.69	−$41.8K	236,384
2026-05-01	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$7.80	+$39K	241,984
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,200 sh	$62.58	−$138K	239,784
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,800 sh	$64.15	−$115K	237,984
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−300 sh	$65.10	−$19.5K	237,684
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−400 sh	$66.06	−$26.4K	237,284
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−200 sh	$67.16	−$13.4K	237,084
2026-05-01	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−100 sh	$68.48	−$6,848	236,984
2026-05-01	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	84,996
2026-03-16	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−600 sh	$41.30	−$24.8K	236,984
2026-03-02	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$7.80	+$39K	242,584
2026-03-02	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,325 sh	$33.28	−$77.4K	240,259
2026-03-02	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−2,675 sh	$33.81	−$90.4K	237,584
2026-03-02	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	89,996
2026-01-23	ORKAOruka Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+32.5K sh	—	—	237,584
2026-01-23	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+130K sh	—	—	130,000
2026-01-02	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$7.80	+$39K	218,084
2026-01-02	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−8,748 sh	$28.17	−$246K	209,336
2026-01-02	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−3,144 sh	$29.08	−$91.4K	206,192
2026-01-02	ORKAOruka Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−1,108 sh	$29.75	−$33K	205,084
2026-01-02	ORKAOruka Therapeutics, Inc. · Employee Warrant (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	94,996
2025-07-01	ORKAOruka Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+25K sh	—	—	25,000

Recent filings

Accepted (ET)
Sep 154
Sandler Laura Lee0000907654-26-000094
SEC(opens sec.gov)
Sep 14
Sandler Laura Lee0000907654-26-000088
SEC(opens sec.gov)
Jul 14
Sandler Laura Lee0000907654-26-000069
SEC(opens sec.gov)
Jun 154
Sandler Laura Lee0000907654-26-000061
SEC(opens sec.gov)
May 14
Sandler Laura Lee0000907654-26-000037
SEC(opens sec.gov)
Mar 174
Sandler Laura Lee0000907654-26-000031
SEC(opens sec.gov)

Companies

Oruka Therapeutics, Inc.Chief Operating OfficerORKA

Address

C/O ORUKA THERAPEUTICS, INC. 855 OAK GROVE AVE., SUITE 100

MENLO PARK, CA, 94025